Market revenue in 2022 | USD 10.8 million |
Market revenue in 2030 | USD 16.9 million |
Growth rate | 5.8% (CAGR from 2022 to 2030) |
Largest segment | Morphine |
Fastest growing segment | Bupivacaine |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Other Type |
Key market players worldwide | Medtronic PLC, Smiths Group PLC, Teleflex Inc, Johnson & Johnson, Medallion Therapeutics, Tricumed Medical Technology, Arrow International Inc, Flowonix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intrathecal pumps market will help companies and investors design strategic landscapes.
Morphine was the largest segment with a revenue share of 31.48% in 2022. Horizon Databook has segmented the France intrathecal pumps market based on baclofen, bupivacaine, clonidine, morphine, ziconotide, other type covering the revenue growth of each sub-segment from 2017 to 2030.
Aging population is at a higher risk of developing spinal disorders. Increase in aging population in France is expected to boost the number of patients with spine problems. The aging population in France is expected to grow over the forecast period at the average annual rate of 0.96%.
Moreover, growing prevalence of cancer in the country is also expected to drive the need for intrathecal drug delivery for cancer pain management. As per World Health Organization (WHO), in 2020, 467,965 new cancer cases were recorded in France.
As per the European Society for Medical Oncology (ESMO), clinical practice guidelines for ITDD are used for cancer management in patients with low life expectancy and with near-normal life expectancy. In France, since 2015, ITDD implants have risen by 20% annually.
Horizon Databook provides a detailed overview of country-level data and insights on the France intrathecal pumps market, including forecasts for subscribers. This country databook contains high-level insights into France intrathecal pumps market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account